Mol Biol Cell 17:50045016 Byron A, Askari JA, Humphries JD, Jacquemet G, Koper EJ, Warwood S, Choi CK, Stroud MJ, Chen CS, Knight D, Humphries MJ (2015) A proteomic approach reveals integrin activation state-dependent control of microtubule cortical targeting
Samples were prepared with TA (30, 150, and 300 g/mL) [26], EDTA (100, 500, and 1000 g/mL) [27], and AA (10, 50, and 100 g/mL) [28] due to their applications in reducing oxidation and scavenging free radicals in both ophthalmic and non-ophthalmic settings
3,4 This receptor and its agonists hold significant therapeutic potential, reshaping the treatment approaches for multiple diseases, including diabetes, cardiovascular disorders, and neurodegenerative diseases
After the completion of the familiarization the animals were supplemented for 10 consecutive days (Days 514) in a randomized, placebo-controlled fashion
There are no fillers or preservatives